Overview
Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT
Status:
Unknown status
Unknown status
Trial end date:
2018-11-01
2018-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a prospective case-control study to compare the usefulness of 18F-FDG PET/MRI with that of 18F-FDG PET/CT in detection of functioning pituitary microadenomas.A single dose of 370 Mega-Becquerel (MBq) 18F-FDG will be injected intravenously.Visual and semiquantitative method will be used to assess the PET/MRI and PET/CT images.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Peking Union Medical College HospitalTreatments:
Fluorodeoxyglucose F18
Criteria
Inclusion Criteria:- Patients who were pathologically diagnosed with pituitary adenoma after surgery were
recruited, and were able to provide basic information and sign the written informed
consent form.
Exclusion Criteria:
- The exclusion criteria included claustrophobia, kidney or liver failure, and inability
to fulfill the study.